相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global trends in diabetes complications: a review of current evidence
Jessica L. Harding et al.
DIABETOLOGIA (2019)
Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
Habib Yaribeygi et al.
DRUG DISCOVERY TODAY (2019)
A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Interleukin-18 and diabetic nephropathy: A review
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Elucidating the role of Lkb1 and mTOR in adipose tissue
Ziye Xu et al.
ADIPOCYTE (2019)
Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice
G. Kim et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
The effect of dapagliflozin treatment on epicardial adipose tissue volume
Takao Sato et al.
CARDIOVASCULAR DIABETOLOGY (2018)
The role of adipokines in skeletal muscle inflammation and insulin sensitivity
Thomas Nicholson et al.
JOURNAL OF INFLAMMATION-LONDON (2018)
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment
Habib Yaribeygi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
W. Timothy Garvey et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Metabolomic and microarray analyses of adipose tissue of dapagliflozin-treated mice, and effects of 3-hydroxybutyrate on induction of adiponectin in adipocytes
Shigeki Nishitani et al.
SCIENTIFIC REPORTS (2018)
Complications of Diabetes 2017
Konstantinos Papatheodorou et al.
JOURNAL OF DIABETES RESEARCH (2018)
Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease
Tuula Saukkonen et al.
SCIENTIFIC REPORTS (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System
Habib Yaribeygi et al.
DRUG RESEARCH (2018)
Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
Rebecca K. C. Loh et al.
DIABETOLOGIA (2018)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis
Shunqin Wang et al.
BRAZILIAN ORAL RESEARCH (2017)
Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
Xiaowei Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity
Mostafa Wanees Ahmed El Husseny et al.
JOURNAL OF DIABETES RESEARCH (2017)
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
Liang Xu et al.
EBIOMEDICINE (2017)
Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway
Anping Wang et al.
PLOS ONE (2017)
Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats
Ichiro Tokubuchi et al.
PLOS ONE (2017)
Insulin use, adipokine profiles and breast cancer prognosis
Zachary A. P. Wintrob et al.
CYTOKINE (2017)
Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus
Kanwal Rehman et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2017)
Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry
Yoshikazu Sawada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
Gian Paolo Fadini et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Sanggenol F exerts anti-diabetic effects via promoting adipocyte differentiation and modifying adipokines expression
Jing-Jie Zhu et al.
ENDOCRINE (2017)
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis
Bruno Geloneze et al.
DRUGS (2017)
Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
Heidi Storgaard et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Effect of increased adiposity on insulin sensitivity and adipokine concentrations in horses and ponies fed a high fat diet, with or without a once daily high glycaemic meal
N. J. Bamford et al.
EQUINE VETERINARY JOURNAL (2016)
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective
Francesco Zaccardi et al.
POSTGRADUATE MEDICAL JOURNAL (2016)
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Shilpa N. Bhupathiraju et al.
CIRCULATION RESEARCH (2016)
Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Amirhossein Sahebkar et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Effect of basal insulin therapy on vascular endothelial function and adipokine profiles in people with Type 2 diabetes
H. Makino et al.
DIABETIC MEDICINE (2016)
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
Bin Zhou et al.
LANCET (2016)
Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
Xin Liu et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice
Yumiko Chiba et al.
PLOS ONE (2016)
DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acid
Jun Shirakawa et al.
DIABETOLOGY & METABOLIC SYNDROME (2016)
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-A2-Glycoprotein Levels in Patients with Type 2 Diabetes
Xin Liao et al.
SCIENTIFIC REPORTS (2016)
Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes
Pia Zillssen et al.
SCIENTIFIC REPORTS (2016)
Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling
E. Pastel et al.
NUTRITION & DIABETES (2016)
A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats
Kirsten M. Hoelmkjaer et al.
PLOS ONE (2016)
Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus
Reza Fadaei et al.
PLOS ONE (2016)
Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial
Robert Wolk et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
EFFECT OF METFORMIN ON GLUCOSE AND FATTY ACID UTILIZATION IN BROWN ADIPOSE TISSUE
J. Trnovska et al.
ATHEROSCLEROSIS (2015)
The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
Huiting Gao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Adipose Tissue Inflammation in the Pathogenesis of Type 2 Diabetes
Ayano Kohlgruber et al.
CURRENT DIABETES REPORTS (2015)
Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis
Wen Kong et al.
PLOS ONE (2015)
Adipokines in health and disease
Mathias Fasshauer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
Hongkai Zhang et al.
NATURE COMMUNICATIONS (2015)
GLP-1 receptor agonist increases the expression of CTRP3, a novel adipokine, in 3T3-L1 adipocytes through PKA signal pathway
X. Li et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Iron: the hard player in diabetes pathophysiology
J. B. Hansen et al.
ACTA PHYSIOLOGICA (2014)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2014)
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial
Z. Punthakee et al.
DIABETIC MEDICINE (2014)
Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients
Yaping Xin et al.
ENDOCRINE JOURNAL (2014)
Increasing Adiposity Is Associated With Higher Adipokine Levels and Lower Bone Mineral Density in Obese Older Adults
Lina Aguirre et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Targeting inflammation in the treatment of type 2 diabetes: time to start
Marc Y. Donath
NATURE REVIEWS DRUG DISCOVERY (2014)
Adipokines and Lipoproteins: Modulation by Antihyperglycemic and Hypolipidemic Agents
Ali A. Rizvi et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes
Chun-Jun Li et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Adipokines - removing road blocks to obesity and diabetes therapy
Matthias Blueher
MOLECULAR METABOLISM (2014)
FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases
Nobuyuki Itoh
FRONTIERS IN ENDOCRINOLOGY (2014)
The origin and definition of brite versus white and classical brown adipocytes
Matthias Rosenwald et al.
ADIPOCYTE (2014)
The role of leptin/adiponectin ratio in metabolic syndrome and diabetes
Patricio Lopez-Jaramillo et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2014)
Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial
SoJung Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats
Peter M. Schmid et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Epidemiology of Diabetes and Diabetes Complications in the Elderly: An Emerging Public Health Burden
Mark Corriere et al.
CURRENT DIABETES REPORTS (2013)
Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
Henrike Sell et al.
DIABETES CARE (2013)
The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes
N. P. E. Kadoglou et al.
DIABETIC MEDICINE (2013)
Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells
Yoshito Ikeda et al.
FEBS JOURNAL (2013)
Metformin Increases the Novel Adipokine Cartonectin/CTRP3 in Women With Polycystic Ovary Syndrome
Bee K. Tan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The role of adipokines in β-cell failure of type 2 diabetes
Simon J. Dunmore et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea
Radostina Vlaeva Cherneva et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2013)
α-Glucosidase inhibitors and their use in clinical practice
Giuseppe Derosa et al.
ARCHIVES OF MEDICAL SCIENCE (2012)
Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
Jan Bolinder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways
Aung Than et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Adipokines: Biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity
Javier Conde et al.
BIOFACTORS (2011)
Thiazolidinediones Regulate Adipose Lineage Dynamics
Wei Tang et al.
CELL METABOLISM (2011)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Insulin effects in muscle and adipose tissue
George Dimitriadis et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
In vitro and in vivo Effects of Metformin on Human Adipose Tissue Adiponectin
Alessandra Zulian et al.
OBESITY FACTS (2011)
Visfatin Is Regulated by Rosiglitazone in Type 2 Diabetes Mellitus and Influenced by NFκB and JNK in Human Abdominal Subcutaneous Adipocytes
Kirsty C. McGee et al.
PLOS ONE (2011)
Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
Bethany P. Cummings et al.
DIABETES (2010)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression
Le Thi Kim Chung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Jan A. Ehses et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice
Cedric Dray et al.
CELL METABOLISM (2008)
Visfatin: Structure, function and relation to diabetes mellitus and other dysfunctions
Ernest Adeghate
CURRENT MEDICINAL CHEMISTRY (2008)
Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance
Bee K. Tan et al.
DIABETES (2008)
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
Helene von Bibra et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: Implication of different mechanism from pioglitazone
Yukiko Kanda et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus
Hae Jin Kim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
The influence of thiazolidinediones on adipogenesis in vitro and in vivo: Potential modifiers of intramuscular adipose tissue deposition in meat animals1,2
G. J. Hausman et al.
JOURNAL OF ANIMAL SCIENCE (2008)
Adipokines and Insulin Resistance
Katja Rabe et al.
MOLECULAR MEDICINE (2008)
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
Adilson Guilherme et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus
Tetsuya Teranishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Abdominal visceral and subcutaneous adipose tissue compartments - Association with metabolic risk factors in the Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
Adipocytes as regulators of energy balance and glucose homeostasis
Evan D. Rosen et al.
NATURE (2006)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action
Rong-Ze Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF-α levels in Type 2 diabetic patients:: a randomized study
H Shimizu et al.
DIABETIC MEDICINE (2006)
Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels
C Otto et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Visfatin is an adipokine, but it is not regulated by thiazolidinediones
A Hammarstedt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
CS Chu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Intensive insulin therapy in the medical ICU
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Obesity and the role of adipose tissue in inflammation and metabolism
ASG Martin et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity
DJ Dyck et al.
ACTA PHYSIOLOGICA (2006)
Adipose tissue, adipokines, and inflammation
G Fantuzzi
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Regional adiposity and insulin resistance
A Garg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes
H Yokoyama et al.
DIABETES CARE (2004)
Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro
ME Trujillo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes
S Nagasaka et al.
DIABETES CARE (2003)
Resistin and type 2 diabetes: Regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes
PG McTernan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Metabolic effects of visceral fat accumulation in type 2 diabetes
A Gastaldelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
分享论文
